Sector index · Health and life sciences · 2026
Drug discovery, pharmacology, vaccines and therapeutic development.
Ranked universities have at least 20 verified industry works in this sector (2021-2025). Score: volume 30%, reach 25% (company groups with 2+ joint works), repeat partnerships 25% (3+ works over 2+ years) and network influence 20%, each as a percentile within this sector's pool of 638.
| # | University | Country | Score | Works | Partners | Leading partners |
|---|---|---|---|---|---|---|
| 1 | Harvard University | United States | 99.9 | 2,044 | 230 | AstraZeneca, Johnson & Johnson, Pfizer |
| 2 | University of California, San Francisco | United States | 99.7 | 1,318 | 176 | Johnson & Johnson, Pfizer, Novartis |
| 3 | University College London | United Kingdom | 99.7 | 1,393 | 162 | Roche, Johnson & Johnson, AstraZeneca |
| 4 | Icahn School of Medicine at Mount Sinai | United States | 99.3 | 1,243 | 138 | Johnson & Johnson, Bristol-Myers Squibb, UCB Pharma |
| 5 | University of Pennsylvania | United States | 99.0 | 1,040 | 146 | Johnson & Johnson, Pfizer, Merck & Co. (MSD) |
| 6 | University of California San Diego | United States | 99.0 | 954 | 139 | AntiCancer, Johnson & Johnson, Pfizer |
| 7 | Cornell University | United States | 99.0 | 1,112 | 151 | Bristol-Myers Squibb, AstraZeneca, Pfizer |
| 8 | University of California, Los Angeles | United States | 98.8 | 1,074 | 135 | Merck & Co. (MSD), AstraZeneca, Bristol-Myers Squibb |
| 9 | University of Toronto | Canada | 98.7 | 1,120 | 128 | Mediprobe Research, Johnson & Johnson, AstraZeneca |
| 10 | Stanford University | United States | 98.3 | 903 | 136 | AstraZeneca, Johnson & Johnson, Roche |
| 11 | Duke University | United States | 98.1 | 926 | 123 | Novartis, Merck & Co. (MSD), Pfizer |
| 12 | Johns Hopkins University | United States | 98.0 | 868 | 127 | Bristol-Myers Squibb, Johnson & Johnson, Pfizer |
| 13 | Emory University | United States | 97.8 | 866 | 126 | Johnson & Johnson, Bristol-Myers Squibb, Pfizer |
| 14 | University of Washington | United States | 97.7 | 946 | 115 | Johnson & Johnson, Pfizer, Novo Nordisk |
| 15 | Yale University | United States | 97.7 | 928 | 111 | AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb |
| 16 | Washington University in St. Louis | United States | 97.6 | 796 | 129 | Roche, Bristol-Myers Squibb, GlaxoSmithKline |
| 17 | Seoul National University | South Korea | 97.5 | 1,034 | 96 | Samsung, Merck & Co. (MSD), AstraZeneca |
| 18 | University of Michigan | United States | 97.5 | 886 | 119 | Bayer, Johnson & Johnson, Bristol-Myers Squibb |
| 19 | Peking University | China | 97.3 | 828 | 99 | Jiangsu Hengrui Medicine, Merck & Co. (MSD), BeiGene |
| 20 | Chinese Academy of Medical Sciences & Peking Union Medical College | China | 97.0 | 788 | 95 | Merck & Co. (MSD), Jiangsu Hengrui Medicine, AstraZeneca |
| 21 | Université Paris Cité | France | 96.6 | 784 | 109 | Roche, Novartis, Bristol-Myers Squibb |
| 22 | Karolinska Institutet | Sweden | 96.5 | 704 | 98 | AstraZeneca, Johnson & Johnson, Pfizer |
| 23 | University of North Carolina at Chapel Hill | United States | 96.4 | 636 | 111 | Johnson & Johnson, Merck & Co. (MSD), Gilead Sciences |
| 24 | KU Leuven | Belgium | 96.1 | 699 | 92 | Johnson & Johnson, Merck & Co. (MSD), AstraZeneca |
| 24 | Northwestern University | United States | 96.1 | 692 | 106 | AstraZeneca, Bayer, Pfizer |
| 26 | University of Oxford | United Kingdom | 95.6 | 638 | 90 | Johnson & Johnson, Pfizer, Eli Lilly |
| 27 | Sun Yat-sen University | China | 95.6 | 636 | 87 | Jiangsu Hengrui Medicine, BGI Group, Merck & Co. (MSD) |
| 28 | Yonsei University | South Korea | 95.6 | 792 | 87 | Merck & Co. (MSD), AstraZeneca, Johnson & Johnson |
| 29 | Heidelberg University | Germany | 95.5 | 738 | 88 | Johnson & Johnson, Boehringer Ingelheim, Novartis |
| 30 | Oregon Health & Science University | United States | 95.3 | 634 | 90 | Johnson & Johnson, Novartis, AbbVie |
| 31 | University of Pittsburgh | United States | 95.0 | 557 | 94 | Pfizer, Johnson & Johnson, Merck & Co. (MSD) |
| 32 | University of Utah | United States | 94.5 | 569 | 77 | Johnson & Johnson, Pfizer, AstraZeneca |
| 33 | University of Alabama at Birmingham | United States | 94.2 | 559 | 83 | Johnson & Johnson, AbbVie, Pfizer |
| 34 | University of Miami | United States | 94.2 | 518 | 85 | Merck & Co. (MSD), Caris Life Sciences, Carl Zeiss |
| 35 | University of Southern California | United States | 94.2 | 534 | 88 | Bristol-Myers Squibb, Johnson & Johnson, Caris Life Sciences |
| 36 | University of Copenhagen | Denmark | 94.0 | 588 | 71 | Novo Nordisk, AstraZeneca, Nordic Bioscience |
| 37 | Fudan University | China | 93.8 | 504 | 73 | Jiangsu Hengrui Medicine, United Imaging Healthcare, Merck & Co. (MSD) |
| 38 | Medical University of Vienna | Austria | 93.7 | 578 | 73 | Pfizer, Johnson & Johnson, Eli Lilly |
| 39 | Imperial College London | United Kingdom | 93.6 | 584 | 86 | Boehringer Ingelheim, Johnson & Johnson, Novartis |
| 40 | University of Chicago | United States | 93.6 | 504 | 86 | Merck & Co. (MSD), Johnson & Johnson, AstraZeneca |
| 41 | Universität Hamburg | Germany | 93.3 | 537 | 79 | Johnson & Johnson, Novartis, UCB Pharma |
| 42 | Sorbonne Université | France | 93.3 | 546 | 75 | Johnson & Johnson, Pfizer, Roche |
| 43 | Université Paris-Saclay | France | 93.3 | 624 | 70 | Johnson & Johnson, Pfizer, Merck & Co. (MSD) |
| 44 | Ludwig-Maximilians-Universität München | Germany | 93.2 | 532 | 84 | Roche, Novartis, Johnson & Johnson |
| 45 | University of Colorado Denver | United States | 93.2 | 502 | 80 | Bristol-Myers Squibb, Merck & Co. (MSD), AbbVie |
| 46 | Sungkyunkwan University | South Korea | 92.7 | 676 | 63 | AstraZeneca, Merck & Co. (MSD), Johnson & Johnson |
| 47 | Indiana University | United States | 92.6 | 483 | 90 | Eli Lilly, Bristol-Myers Squibb, GlaxoSmithKline |
| 48 | Shanghai Jiao Tong University | China | 92.5 | 502 | 66 | Johnson & Johnson, Bristol-Myers Squibb, AstraZeneca |
| 49 | University of Milan | Italy | 91.8 | 476 | 71 | Roche, AstraZeneca, Novartis |
| 50 | Radboud University Nijmegen | Netherlands | 91.7 | 423 | 75 | Novartis, Merck & Co. (MSD), Johnson & Johnson |
| 51 | University of Manchester | United Kingdom | 91.6 | 450 | 67 | AstraZeneca, Pfizer, Johnson & Johnson |
| 52 | Sichuan University | China | 91.6 | 450 | 69 | Jiangsu Hengrui Medicine, Amgen, Johnson & Johnson |
| 53 | The Ohio State University | United States | 91.5 | 424 | 76 | Bristol-Myers Squibb, Johnson & Johnson, GlaxoSmithKline |
| 54 | Georgetown University | United States | 91.4 | 394 | 71 | Caris Life Sciences, Merck & Co. (MSD), Johnson & Johnson |
| 55 | King's College London | United Kingdom | 91.3 | 442 | 72 | Johnson & Johnson, Roche, AstraZeneca |
| 56 | National and Kapodistrian University of Athens | Greece | 91.1 | 546 | 64 | Boehringer Ingelheim, Johnson & Johnson, Bristol-Myers Squibb |
| 57 | Lund University | Sweden | 91.0 | 348 | 71 | Roche, Johnson & Johnson, AstraZeneca |
| 58 | University of Florida | United States | 90.8 | 338 | 77 | Merck & Co. (MSD), Boston Scientific, AbbVie |
| 59 | The University of Melbourne | Australia | 90.6 | 488 | 66 | Johnson & Johnson, Roche, Merck & Co. (MSD) |
| 60 | University of Glasgow | United Kingdom | 90.3 | 608 | 56 | AstraZeneca, Novartis, Johnson & Johnson |
| 61 | University of British Columbia | Canada | 90.3 | 434 | 65 | Johnson & Johnson, Roche, Novartis |
| 62 | University of Minnesota | United States | 90.3 | 390 | 65 | Caris Life Sciences, AstraZeneca, Medtronic |
| 63 | Indiana University - Purdue University Indianapolis | United States | 90.3 | 420 | 82 | Eli Lilly, Bristol-Myers Squibb, GlaxoSmithKline |
| 64 | Charles University | Czechia | 89.8 | 432 | 62 | Sanofi, Merck & Co. (MSD), AstraZeneca |
| 65 | Monash University | Australia | 89.5 | 428 | 60 | AbbVie, Johnson & Johnson, Boehringer Ingelheim |
| 66 | Goethe University Frankfurt | Germany | 89.5 | 408 | 59 | Johnson & Johnson, AbbVie, UCB Pharma |
| 67 | University of Ulsan | South Korea | 89.5 | 529 | 61 | Merck & Co. (MSD), AstraZeneca, Roche |
| 68 | Johannes Gutenberg University Mainz | Germany | 89.1 | 328 | 63 | Novartis, Bristol-Myers Squibb, Boehringer Ingelheim |
| 69 | Capital Medical University | China | 88.6 | 300 | 67 | Genecast, Jiangsu Hengrui Medicine, Philips |
| 70 | The University of Tokyo | Japan | 88.5 | 284 | 61 | Boehringer Ingelheim, Pfizer, Takeda |
| 71 | University of Arizona | United States | 88.2 | 312 | 63 | Merck & Co. (MSD), GlaxoSmithKline, Pfizer |
| 72 | The University of Sydney | Australia | 88.2 | 428 | 57 | Merck & Co. (MSD), Johnson & Johnson, Bristol-Myers Squibb |
| 73 | Rutgers, The State University of New Jersey | United States | 88.0 | 326 | 62 | Merck & Co. (MSD), Pfizer, Roche |
| 73 | Central South University | China | 88.0 | 344 | 54 | Jiangsu Hengrui Medicine, Merck & Co. (MSD), Lilly |
| 75 | Universitat de Barcelona | Spain | 87.9 | 355 | 58 | Johnson & Johnson, AstraZeneca, Roche |
| 76 | University of Gothenburg | Sweden | 87.7 | 410 | 50 | Roche, AstraZeneca, Johnson & Johnson |
| 77 | Uppsala University | Sweden | 87.5 | 320 | 50 | AstraZeneca, Johnson & Johnson, BioArctic |
| 78 | Tel Aviv University | Israel | 86.8 | 335 | 52 | AbbVie, Merck & Co. (MSD), AstraZeneca |
| 79 | University of Calgary | Canada | 86.7 | 349 | 53 | Johnson & Johnson, Pfizer, AstraZeneca |
| 80 | New York University | United States | 86.4 | 320 | 51 | Johnson & Johnson, Pfizer, Emmes |
| 81 | McGill University | Canada | 86.4 | 334 | 53 | Johnson & Johnson, Roche, Merck & Co. (MSD) |
| 82 | University of Maryland, Baltimore | United States | 86.2 | 286 | 60 | AstraZeneca, Johnson & Johnson, GlaxoSmithKline |
| 83 | University of Liverpool | United Kingdom | 86.2 | 312 | 51 | AstraZeneca, TriNetX, Saluda Medical |
| 84 | Columbia University | United States | 86.1 | 298 | 61 | Edwards Lifesciences, Pfizer, AbbVie |
| 85 | Kyoto University | Japan | 86.0 | 262 | 55 | Eli Lilly, Pfizer, Ono Pharmaceutical |
| 86 | University of Bologna | Italy | 85.8 | 300 | 57 | Johnson & Johnson, Bristol-Myers Squibb, Merck & Co. (MSD) |
| 87 | University of Alberta | Canada | 85.8 | 308 | 53 | Merck & Co. (MSD), Bayer, Johnson & Johnson |
| 88 | University of Groningen | Netherlands | 85.7 | 418 | 43 | AstraZeneca, Bayer, Novartis |
| 89 | The University of Osaka | Japan | 85.5 | 276 | 55 | Novartis, Ono Pharmaceutical, AstraZeneca |
| 90 | Case Western Reserve University | United States | 85.4 | 297 | 62 | UCB Pharma, AbbVie, Bristol-Myers Squibb |
| 91 | Universitat Autònoma de Barcelona | Spain | 85.4 | 334 | 51 | Johnson & Johnson, Eli Lilly, Novartis |
| 92 | Queen Mary University of London | United Kingdom | 85.2 | 372 | 47 | Merck & Co. (MSD), AstraZeneca, Pfizer |
| 93 | Weill Cornell Medicine | United States | 85.0 | 350 | 56 | Pfizer, Johnson & Johnson, Bristol-Myers Squibb |
| 94 | Baylor College of Medicine | United States | 84.9 | 290 | 62 | Akebia Therapeutics, Boehringer Ingelheim, AstraZeneca |
| 95 | Ulsan College | South Korea | 84.8 | 430 | 50 | Merck & Co. (MSD), AstraZeneca, Pfizer |
| 96 | Zhejiang University | China | 84.7 | 290 | 47 | Jiangsu Hengrui Medicine, BeiGene, Betta Pharmaceuticals |
| 97 | University of Wisconsin-Madison | United States | 84.6 | 286 | 50 | Roche, Johnson & Johnson, AstraZeneca |
| 98 | Newcastle University | United Kingdom | 84.5 | 278 | 58 | AstraZeneca, Novartis, Johnson & Johnson |
| 99 | Wake Forest University | United States | 84.4 | 316 | 53 | Johnson & Johnson, Bristol-Myers Squibb, AbbVie |
| 100 | University of Cambridge | United Kingdom | 84.3 | 288 | 50 | AstraZeneca, GlaxoSmithKline, Novartis |
| 101 | Huazhong University of Science and Technology | China | 84.2 | 294 | 49 | Jiangsu Hengrui Medicine, BeiGene, Roche |
| 102 | Keio University | Japan | 84.2 | 266 | 46 | AstraZeneca, Merck & Co. (MSD), Galapagos |
| 103 | University of Tübingen | Germany | 84.1 | 276 | 51 | Johnson & Johnson, Novartis, Bayer |
| 104 | National University of Singapore | Singapore | 84.0 | 394 | 45 | Bayer, AstraZeneca, Novartis |
| 105 | Kindai University | Japan | 84.0 | 385 | 38 | Bristol-Myers Squibb, AstraZeneca, Eli Lilly |
| 106 | Medical College of Wisconsin | United States | 83.8 | 328 | 50 | Johnson & Johnson, Novartis, Bristol-Myers Squibb |
| 107 | Boston University | United States | 83.8 | 276 | 48 | Pfizer, Chondrometrics, Novartis |
| 108 | University of Cincinnati | United States | 83.7 | 253 | 53 | Eli Lilly, Caris Life Sciences, Johnson & Johnson |
| 109 | University of Colorado Anschutz Medical Campus | United States | 83.6 | 280 | 52 | Merck & Co. (MSD), Bayer, AstraZeneca |
| 110 | University of Rochester | United States | 83.4 | 318 | 47 | Johnson & Johnson, Roche, GlaxoSmithKline |
| 111 | Southern Medical University | China | 83.0 | 250 | 52 | AstraZeneca, Jiangsu Hengrui Medicine, Philips |
| 112 | University of Turin | Italy | 83.0 | 292 | 47 | Novartis, Johnson & Johnson, Pfizer |
| 113 | McMaster University | Canada | 82.7 | 280 | 50 | Bayer, Johnson & Johnson, Eli Lilly |
| 114 | Harbin Medical University | China | 82.6 | 348 | 44 | Jiangsu Hengrui Medicine, BeiGene, Roche |
| 115 | Université de Montréal | Canada | 81.9 | 257 | 48 | Novartis, Pfizer, AstraZeneca |
| 116 | Kyushu University | Japan | 81.8 | 262 | 40 | Merck & Co. (MSD), Daiichi Sankyo, Eisai |
| 117 | Catholic University of Korea | South Korea | 81.7 | 283 | 40 | Samsung, Johnson & Johnson, Regeneron |
| 118 | University of California, Irvine | United States | 81.5 | 266 | 43 | Takeda, Merck & Co. (MSD), Johnson & Johnson |
| 119 | University of Helsinki | Finland | 81.4 | 238 | 47 | Oncopeptides, Pfizer, Orion Corporation |
| 120 | Virginia Commonwealth University | United States | 81.1 | 234 | 51 | Pfizer, Histoindex, Novo Nordisk |
| 121 | University of Zurich | Switzerland | 81.0 | 256 | 45 | Novartis, Gilead Sciences, Merck & Co. (MSD) |
| 122 | Technical University of Munich | Germany | 81.0 | 252 | 45 | Novartis, Roche, Boehringer Ingelheim |
| 123 | University of Lübeck | Germany | 80.8 | 300 | 41 | Bristol-Myers Squibb, Johnson & Johnson, UCB Pharma |
| 124 | Aix-Marseille Université | France | 80.5 | 277 | 42 | Bristol-Myers Squibb, Roche, Merck & Co. (MSD) |
| 125 | University of Amsterdam | Netherlands | 80.4 | 222 | 52 | Novartis, Roche, Johnson & Johnson |
| 126 | Université Claude Bernard Lyon 1 | France | 80.3 | 276 | 47 | Roche, Novartis, AstraZeneca |
| 127 | Medizinische Hochschule Hannover | Germany | 80.1 | 259 | 41 | Merck & Co. (MSD), Bayer, AstraZeneca |
| 128 | Utrecht University | Netherlands | 80.0 | 210 | 44 | Servier, Royal GD, AstraZeneca |
| 129 | Vrije Universiteit Amsterdam | Netherlands | 79.9 | 279 | 43 | Johnson & Johnson, Roche, Bristol-Myers Squibb |
| 130 | University of California, Davis | United States | 79.7 | 228 | 47 | Merck & Co. (MSD), AstraZeneca, AbbVie |
| 131 | Yokohama City University | Japan | 79.6 | 234 | 41 | Echosens, AntiCancer, Takeda |
| 132 | Juntendo University | Japan | 79.4 | 220 | 42 | PharmaEssentia Corporation, Eisai, Takeda |
| 133 | Vita-Salute San Raffaele University | Italy | 79.4 | 260 | 45 | Johnson & Johnson, Bayer, Gilead Sciences |
| 134 | University of Edinburgh | United Kingdom | 79.4 | 240 | 45 | AstraZeneca, Bayer, Novo Nordisk |
| 135 | Université de Lille | France | 79.3 | 263 | 44 | Roche, Johnson & Johnson, Bristol-Myers Squibb |
| 136 | University of Leeds | United Kingdom | 79.0 | 268 | 39 | Johnson & Johnson, Novartis, Pfizer |
| 137 | University of Naples Federico II | Italy | 78.7 | 213 | 43 | Novartis, Recordati, Synlab Czech |
| 138 | Chinese University of Hong Kong | Hong Kong | 78.6 | 301 | 38 | AstraZeneca, Pfizer, Roche |
| 139 | Heinrich Heine University Düsseldorf | Germany | 78.5 | 230 | 39 | Novartis, Boston Scientific, AstraZeneca |
| 140 | Zhengzhou University | China | 78.5 | 234 | 40 | Jiangsu Hengrui Medicine, BeiGene, AstraZeneca |
| 141 | The University of Texas at San Antonio Health Science Center | United States | 78.2 | 215 | 47 | Novartis, AbbVie, Gilead Sciences |
| 142 | Maastricht University | Netherlands | 78.2 | 213 | 48 | Synapse, Johnson & Johnson, UCB Pharma |
| 143 | University of Padua | Italy | 77.9 | 242 | 40 | AbbVie, Bial, Relmada Therapeutics |
| 144 | Nanjing Medical University | China | 77.8 | 227 | 38 | Jiangsu Hengrui Medicine, Simcere Pharmaceutical, United Imaging Healthcare |
| 145 | University of Bern | Switzerland | 77.6 | 222 | 42 | Roche, Gilead Sciences, Eli Lilly |
| 146 | Jilin University | China | 77.5 | 222 | 42 | Jiangsu Hengrui Medicine, BeiGene, Roche |
| 147 | University of Oslo | Norway | 77.4 | 220 | 38 | Novartis, AstraZeneca, Johnson & Johnson |
| 148 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Germany | 77.4 | 232 | 37 | Novartis, Chondrometrics, Novo Nordisk |
| 149 | Shandong First Medical University | China | 76.7 | 248 | 32 | Jiangsu Hengrui Medicine, Qilu Pharmaceutical Co., Innovent Biologics |
| 150 | The University of Queensland | Australia | 76.5 | 208 | 40 | Merck & Co. (MSD), Johnson & Johnson, Pfizer |
| 151 | University of Florence | Italy | 76.2 | 214 | 42 | Novartis, Johnson & Johnson, Constellation Pharmaceuticals |
| 152 | Thomas Jefferson University | United States | 76.2 | 214 | 39 | Neurelis, Bayer, Merck & Co. (MSD) |
| 153 | Brown University | United States | 76.1 | 206 | 42 | Caris Life Sciences, Roche, AstraZeneca |
| 154 | Nantes Université | France | 76.0 | 282 | 38 | Johnson & Johnson, Roche, Sanofi |
| 155 | University of Virginia | United States | 75.6 | 204 | 44 | Merck & Co. (MSD), Roche, Johnson & Johnson |
| 156 | Semmelweis University | Hungary | 75.5 | 206 | 37 | Johnson & Johnson, Syreon Research Institute, Pharmahungary Group |
| 157 | Vanderbilt University | United States | 75.5 | 224 | 39 | Pfizer, Merck & Co. (MSD), Takeda |
| 158 | China Medical University | China | 75.5 | 224 | 39 | Jiangsu Hengrui Medicine, Qilu Pharmaceutical Co., BeiGene |
| 159 | University of Iowa | United States | 75.5 | 207 | 38 | Pfizer, Merck & Co. (MSD), Bristol-Myers Squibb |
| 160 | Humboldt-Universität zu Berlin | Germany | 74.8 | 216 | 39 | ClinAssess, UCB Pharma, Novartis |
| 161 | Medical University of South Carolina | United States | 74.6 | 208 | 38 | Novartis, GlaxoSmithKline, Eli Lilly |
| 162 | Hokkaido University | Japan | 74.2 | 166 | 36 | Ono Pharmaceutical, Galapagos, Chugai Pharmaceutical Co. |
| 163 | Erasmus University Rotterdam | Netherlands | 73.9 | 188 | 43 | Johnson & Johnson, AstraZeneca, Julius Clinical Research BV |
| 164 | Sapienza University of Rome | Italy | 73.7 | 212 | 37 | Novartis, AbbVie, Merck & Co. (MSD) |
| 165 | The University of Texas Health Science Center at Houston | United States | 73.6 | 183 | 39 | Almirall, Takeda, Novartis |
| 166 | George Washington University | United States | 73.2 | 185 | 36 | Pfizer, Bayer, Bausch Health |
| 167 | University of Freiburg | Germany | 73.2 | 199 | 34 | Novartis, Johnson & Johnson, UCB Pharma |
| 168 | Guangzhou Medical University | China | 73.2 | 184 | 40 | Jiangsu Hengrui Medicine, BGI Group, Qilu Pharmaceutical Co. |
| 169 | Ruhr University Bochum | Germany | 73.0 | 212 | 36 | Novartis, AbbVie, UCB Pharma |
| 170 | University of Chinese Academy of Sciences | China | 73.0 | 202 | 32 | BGI Group, Burning Rock Biotech, Jiangsu Hengrui Medicine |
| 171 | University of Lausanne | Switzerland | 72.9 | 198 | 35 | Novartis, Johnson & Johnson, Bristol-Myers Squibb |
| 172 | University of Birmingham | United Kingdom | 72.5 | 173 | 41 | Novo Nordisk, Echosens, Synapse |
| 173 | Université de Montpellier | France | 72.5 | 186 | 33 | Roche, AstraZeneca, Eli Lilly |
| 174 | University of South Florida | United States | 72.5 | 154 | 37 | AbbVie, Boston Scientific, AstraZeneca |
| 175 | Université de Bordeaux | France | 72.3 | 194 | 33 | Roche, Bayer, Novartis |
| 175 | Wayne State University | United States | 72.3 | 192 | 40 | Caris Life Sciences, Johnson & Johnson, Merck & Co. (MSD) |
| 177 | Korea University | South Korea | 72.3 | 181 | 35 | Samsung, Hanmi Pharmaceutical, Johnson & Johnson |
| 178 | UNSW Sydney | Australia | 72.2 | 228 | 25 | AstraZeneca, Johnson & Johnson, Novo Nordisk |
| 179 | Freie Universität Berlin | Germany | 71.9 | 188 | 34 | Novartis, ClinAssess, Boehringer Ingelheim |
| 180 | University of Southern Denmark | Denmark | 71.8 | 177 | 33 | Johnson & Johnson, Roche, Nordic Bioscience |
| 181 | Fujian Medical University | China | 71.4 | 174 | 33 | Jiangsu Hengrui Medicine, BeiGene, Siemens |
| 182 | University of Antwerp | Belgium | 70.8 | 153 | 37 | Johnson & Johnson, AC Immune, AstraZeneca |
| 183 | University of Pisa | Italy | 70.6 | 186 | 31 | Johnson & Johnson, Novartis, Abbott |
| 184 | University of Sheffield | United Kingdom | 70.4 | 160 | 34 | Johnson & Johnson, AstraZeneca, Bayer |
| 185 | University of Pavia | Italy | 70.4 | 152 | 30 | Astellas Pharma, Bristol-Myers Squibb, AstraZeneca |
| 186 | Nagoya University | Japan | 70.2 | 151 | 32 | AstraZeneca, Merck KGaA, Merck & Co. (MSD) |
| 187 | Universidade do Porto | Portugal | 70.1 | 183 | 24 | Boehringer Ingelheim, Bial, AstraZeneca |
| 188 | Hebei Medical University | China | 70.1 | 164 | 33 | Jiangsu Hengrui Medicine, CSPC Pharmaceutical Group, Simcere Pharmaceutical |
| 189 | University of Bonn | Germany | 70.0 | 170 | 31 | Roche, Bayer, Novartis |
| 190 | Nagoya City University | Japan | 70.0 | 200 | 25 | Bristol-Myers Squibb, Boehringer Ingelheim, UCB Pharma |
| 191 | University of Basel | Switzerland | 69.6 | 157 | 26 | Novartis, Roche, Helsana Group |
| 192 | Innsbruck Medical University | Austria | 69.6 | 180 | 30 | Merck & Co. (MSD), Bial, Eisai |
| 193 | University of Hong Kong | Hong Kong | 68.8 | 170 | 29 | Merck & Co. (MSD), Pfizer, AstraZeneca |
| 194 | Albert Einstein College of Medicine | United States | 68.8 | 167 | 32 | Merck & Co. (MSD), GlaxoSmithKline, Caris Life Sciences |
| 195 | London School of Hygiene & Tropical Medicine | United Kingdom | 68.7 | 164 | 31 | Boehringer Ingelheim, GlaxoSmithKline, Johnson & Johnson |
| 196 | Western University | Canada | 68.5 | 160 | 34 | Novartis, Alimentiv Inc., Johnson & Johnson |
| 197 | University of Illinois Chicago | United States | 68.3 | 159 | 29 | AbbVie, Mycosynthetix, Cerner |
| 198 | Tohoku University | Japan | 68.2 | 124 | 31 | Chugai Pharmaceutical Co., AbbVie, Takeda |
| 199 | UCLouvain | Belgium | 68.0 | 146 | 41 | Johnson & Johnson, Roche, Pfizer |
| 200 | Saarland University | Germany | 67.9 | 148 | 28 | Boehringer Ingelheim, Bayer, Novo Nordisk |
| 201 | University of Milano-Bicocca | Italy | 67.9 | 174 | 29 | Bayer, Merck & Co. (MSD), Pfizer |
| 202 | Universidade de São Paulo | Brazil | 67.8 | 148 | 26 | Fleury S.A., Johnson & Johnson, Merck & Co. (MSD) |
| 203 | Tongji University | China | 67.8 | 152 | 28 | Jiangsu Hengrui Medicine, Roche, Johnson & Johnson |
| 204 | University of Cologne | Germany | 67.7 | 172 | 36 | Johnson & Johnson, Bristol-Myers Squibb, Merck & Co. (MSD) |
| 205 | Universidad Complutense de Madrid | Spain | 67.4 | 118 | 32 | Bristol-Myers Squibb, Johnson & Johnson, AstraZeneca |
| 206 | Université Laval | Canada | 67.3 | 180 | 26 | Edwards Lifesciences, Merck & Co. (MSD), Johnson & Johnson |
| 207 | Soochow University | China | 67.2 | 154 | 27 | Jiangsu Hengrui Medicine, Innovent Biologics, Johnson & Johnson |
| 208 | Medical University of Graz | Austria | 66.8 | 143 | 35 | Pfizer, Merck & Co. (MSD), Almirall |
| 209 | Anhui Medical University | China | 66.8 | 172 | 28 | Jiangsu Hengrui Medicine, Innovent Biologics, Merck & Co. (MSD) |
| 210 | University College Dublin | Ireland | 66.6 | 129 | 30 | Eli Lilly, Pfizer, Boehringer Ingelheim |
| 211 | University of Bari Aldo Moro | Italy | 66.3 | 141 | 26 | Eli Lilly, Merck & Co. (MSD), Novartis |
| 212 | Jagiellonian University | Poland | 66.2 | 119 | 28 | Johnson & Johnson, Simcyp, Bristol-Myers Squibb |
| 213 | University of Tennessee Health Science Center | United States | 66.2 | 160 | 24 | Merck & Co. (MSD), Pfizer, Neurelis |
| 214 | University of Nottingham | United Kingdom | 66.1 | 132 | 24 | AstraZeneca, Pfizer, Novartis |
| 215 | Toho University | Japan | 66.0 | 122 | 27 | Daiichi Sankyo, Sanofi, AbbVie |
| 216 | Cardiff University | United Kingdom | 65.5 | 133 | 33 | Novartis, UCB Pharma, AbbVie |
| 217 | Massachusetts Institute of Technology | United States | 65.5 | 143 | 26 | GlaxoSmithKline, Moderna Therapeutics, Philips |
| 218 | Università Cattolica del Sacro Cuore | Italy | 65.4 | 166 | 28 | Novartis, Merck & Co. (MSD), Johnson & Johnson |
| 219 | University of Ottawa | Canada | 65.3 | 156 | 28 | Johnson & Johnson, AstraZeneca, Novartis |
| 220 | University of Turku | Finland | 65.2 | 117 | 30 | Bioptic Laboratory, Orion Corporation, Novartis |
| 221 | Queen's University | Canada | 64.7 | 152 | 28 | Bristol-Myers Squibb, UCB Pharma, BioTherapeutics |
| 222 | University of Arkansas for Medical Sciences | United States | 64.7 | 140 | 26 | Nevro, Johnson & Johnson, Saluda Medical |
| 223 | University of Tsukuba | Japan | 64.5 | 121 | 24 | Merck & Co. (MSD), Daiichi Sankyo, Ono Pharmaceutical |
| 224 | Qingdao University | China | 64.4 | 120 | 27 | Jiangsu Hengrui Medicine, Qilu Pharmaceutical Co., Junshi Biosciences |
| 225 | RWTH Aachen University | Germany | 64.3 | 134 | 25 | Novartis, Bayer, Novo Nordisk |
| 226 | Technische Universität Dresden | Germany | 64.2 | 136 | 30 | Novartis, AstraZeneca, Johnson & Johnson |
| 227 | University of Liège | Belgium | 63.9 | 124 | 27 | Artialis SA, Nordic Bioscience, Novartis |
| 228 | Kanazawa University | Japan | 63.8 | 122 | 25 | AntiCancer, Eisai, Johnson & Johnson |
| 229 | Chiba University | Japan | 63.8 | 110 | 29 | Merck & Co. (MSD), Chugai Pharmaceutical Co., Ono Pharmaceutical |
| 230 | University of Verona | Italy | 63.4 | 143 | 25 | UCB Pharma, Novartis, Eli Lilly |
| 231 | University of Siena | Italy | 62.8 | 127 | 23 | Bristol-Myers Squibb, Lundbeck, Johnson & Johnson |
| 232 | Universidad de Salamanca | Spain | 62.6 | 147 | 27 | Johnson & Johnson, Bristol-Myers Squibb, Amgen |
| 233 | Kitasato University | Japan | 62.6 | 115 | 22 | Takeda, Pfizer, Gilead Sciences |
| 234 | Trinity College Dublin | Ireland | 62.2 | 109 | 24 | Aerogen, Johnson & Johnson, AstraZeneca |
| 235 | University of Southampton | United Kingdom | 62.2 | 126 | 25 | Roche, Echosens, AstraZeneca |
| 236 | University of Lisbon | Portugal | 62.1 | 128 | 22 | Bial, Hovione, Johnson & Johnson |
| 237 | China Medical University | Taiwan | 61.6 | 120 | 29 | AstraZeneca, Merck & Co. (MSD), Bristol-Myers Squibb |
| 238 | Linköping University | Sweden | 61.5 | 112 | 27 | Novartis, AstraZeneca, Pfizer |
| 239 | Nanchang University | China | 61.5 | 162 | 25 | Jiangsu Hengrui Medicine, HUTCHMED (China) Limited, Junshi Biosciences |
| 240 | Université Libre de Bruxelles | Belgium | 61.1 | 122 | 28 | Gilead Sciences, Roche, Merck & Co. (MSD) |
| 241 | Ghent University | Belgium | 60.9 | 132 | 23 | Johnson & Johnson, AbbVie, Novartis |
| 242 | Queen's University Belfast | United Kingdom | 60.6 | 112 | 29 | Roche, Novartis, AstraZeneca |
| 243 | Leipzig University | Germany | 60.4 | 108 | 24 | Novartis, Merck & Co. (MSD), Invicro |
| 244 | New York Medical College | United States | 60.4 | 82 | 25 | Otsuka, Otsuka Pharmaceutical Development & Commercialization, Teva Pharmaceuticals |
| 245 | Dalhousie University | Canada | 60.3 | 149 | 21 | Johnson & Johnson, UCB Pharma, AbbVie |
| 246 | National Taiwan University | Taiwan | 60.2 | 124 | 24 | Johnson & Johnson, Merck KGaA, Takeda |
| 247 | Université Toulouse III - Paul Sabatier | France | 60.1 | 133 | 23 | Johnson & Johnson, Sanofi, Roche |
| 248 | Aarhus University | Denmark | 60.1 | 106 | 25 | Novo Nordisk, Amgen, Eli Lilly |
| 249 | Kobe University | Japan | 59.4 | 97 | 27 | Kansai Electric Power, Ono Pharmaceutical, Merck KGaA |
| 250 | University of Duisburg-Essen | Germany | 59.3 | 125 | 20 | Novartis, Johnson & Johnson, DAK-Gesundheit |
| 251 | Niigata University | Japan | 59.3 | 118 | 22 | Bristol-Myers Squibb, Ono Pharmaceutical, Pfizer |
| 252 | Jichi Medical University | Japan | 58.3 | 98 | 21 | Bristol-Myers Squibb, AbbVie, Novartis |
| 253 | Philipps University of Marburg | Germany | 58.2 | 105 | 23 | Merck & Co. (MSD), AstraZeneca, IQVIA |
| 254 | Universität Innsbruck | Austria | 58.1 | 106 | 25 | Bial, Merck & Co. (MSD), Eisai |
| 255 | Chongqing Medical University | China | 58.0 | 116 | 23 | Jiangsu Hengrui Medicine, United Imaging Healthcare, InferVision |
| 256 | Université de Lorraine | France | 57.6 | 166 | 20 | Boehringer Ingelheim, Bayer, Novartis |
| 257 | Kunming Medical University | China | 57.6 | 118 | 23 | Jiangsu Hengrui Medicine, 3D Medicines, Genecast |
| 258 | National Yang Ming Chiao Tung University | Taiwan | 57.5 | 96 | 22 | AstraZeneca, Merck KGaA, Daiichi Sankyo |
| 259 | Universidad de Sevilla | Spain | 57.3 | 109 | 24 | Novartis, Bristol-Myers Squibb, Roche |
| 260 | The University of Adelaide | Australia | 57.2 | 125 | 20 | Novartis, AbbVie, International Drug Development Institute |
| 261 | Chungbuk National University | South Korea | 57.2 | 124 | 17 | Johnson & Johnson, AstraZeneca, Merck & Co. (MSD) |
| 262 | University of Manitoba | Canada | 57.2 | 120 | 18 | Merck & Co. (MSD), AstraZeneca, Novartis |
| 263 | The University of Western Australia | Australia | 57.2 | 114 | 20 | MMGH Consulting, AbbVie, Roche |
| 264 | University of the Witwatersrand | South Africa | 57.0 | 116 | 21 | GlaxoSmithKline, Gilead Sciences, Roche |
| 265 | Wenzhou Medical University | China | 57.0 | 106 | 22 | Echosens, AstraZeneca, Jiangsu Hengrui Medicine |
| 266 | Universidad de Navarra | Spain | 56.9 | 95 | 29 | Johnson & Johnson, Merck & Co. (MSD), Roche |
| 267 | Leiden University | Netherlands | 56.9 | 90 | 24 | Sanofi, GlaxoSmithKline, Servier |
| 268 | Université Grenoble Alpes | France | 56.9 | 104 | 24 | Roche, Bristol-Myers Squibb, AstraZeneca |
| 269 | Kyung Hee University | South Korea | 56.7 | 106 | 17 | Samsung, Eni, Boehringer Ingelheim |
| 270 | Providence College | United States | 56.7 | 120 | 17 | GlaxoSmithKline, AstraZeneca, Johnson & Johnson |
| 271 | Chongqing University | China | 56.5 | 101 | 20 | Jiangsu Hengrui Medicine, Johnson & Johnson, Kelun Group |
| 272 | Mahidol University | Thailand | 56.4 | 108 | 23 | Merck & Co. (MSD), Pfizer, Roche |
| 273 | Tulane University | United States | 56.2 | 104 | 22 | Novartis, Bayer, Sanofi |
| 274 | University of Missouri-Kansas City | United States | 56.0 | 151 | 21 | AstraZeneca, Boehringer Ingelheim, Novo Nordisk |
| 275 | University of Bristol | United Kingdom | 55.6 | 98 | 18 | AstraZeneca, GlaxoSmithKline, Eli Lilly |
| 276 | Tokai University | Japan | 55.5 | 100 | 21 | Kyowa Kirin, Daiichi Sankyo, Suzuki |
| 277 | Medical University of Lodz | Poland | 55.4 | 99 | 26 | AstraZeneca, Syreon Research Institute, Takeda |
| 278 | Wuhan University | China | 55.1 | 98 | 19 | PharmaEssentia Corporation, CSPC Pharmaceutical Group, Euler Technology |
| 279 | Université de Rouen Normandie | France | 55.0 | 105 | 17 | Roche, Edwards Lifesciences, IPPMed |
| 280 | University of Massachusetts Chan Medical School | United States | 54.8 | 92 | 22 | CorEvitas, Novartis, Bristol-Myers Squibb |
| 281 | University of Genoa | Italy | 54.5 | 102 | 19 | Pfizer, Eli Lilly, Roche |
| 282 | University of Debrecen | Hungary | 53.8 | 92 | 21 | Pfizer, Takeda, Merck & Co. (MSD) |
| 283 | Kyungpook National University | South Korea | 53.8 | 94 | 18 | Samsung, AstraZeneca, Pfizer |
| 284 | Justus-Liebig-Universität Gießen | Germany | 53.8 | 97 | 19 | Bristol-Myers Squibb, Sanofi, Merck & Co. (MSD) |
| 285 | University of Würzburg | Germany | 53.0 | 122 | 17 | Oncopeptides, Boehringer Ingelheim, GlaxoSmithKline |
| 286 | ETH Zurich | Switzerland | 53.0 | 82 | 18 | Roche, Novartis, Merck KGaA |
| 287 | University of Exeter | United Kingdom | 52.9 | 78 | 26 | Roche, Otsuka, Acadia Pharmaceuticals |
| 288 | University of Geneva | Switzerland | 52.8 | 96 | 22 | Johnson & Johnson, Pierre Fabre, UCB Pharma |
| 289 | Shandong University | China | 52.2 | 90 | 16 | Jiangsu Hengrui Medicine, United Imaging Healthcare, Lilly |
| 290 | University at Buffalo, State University of New York | United States | 52.0 | 81 | 20 | Enhanced Pharmacodynamics, Merck & Co. (MSD), Emmes |
| 291 | University of Campania "Luigi Vanvitelli" | Italy | 51.7 | 90 | 16 | Pfizer, Servier, Institut de Recherches Internationales Servier |
| 292 | Universidad Autónoma de Madrid | Spain | 51.7 | 94 | 20 | Roche, Pfizer, Johnson & Johnson |
| 293 | University of Louisville | United States | 51.6 | 90 | 20 | Merck & Co. (MSD), Pfizer, GlaxoSmithKline |
| 294 | University of Kentucky | United States | 51.5 | 80 | 26 | Bristol-Myers Squibb, Emmes, Caris Life Sciences |
| 295 | China Pharmaceutical University | China | 51.4 | 90 | 17 | Shimadzu, Nanjing Sanhome Pharmaceutical Co., Bristol-Myers Squibb |
| 296 | Poznan University of Medical Sciences | Poland | 51.2 | 97 | 25 | Merck & Co. (MSD), Johnson & Johnson, Bristol-Myers Squibb |
| 297 | Universitat de València | Spain | 51.0 | 84 | 22 | Roche, Boehringer Ingelheim, Astellas Pharma |
| 298 | University of Coimbra | Portugal | 50.8 | 69 | 16 | Bluepharma, Novartis, Boehringer Ingelheim |
| 299 | Macquarie University | Australia | 50.8 | 94 | 19 | Merck & Co. (MSD), Pfizer, Bristol-Myers Squibb |
| 300 | University of Leicester | United Kingdom | 50.6 | 122 | 14 | Novo Nordisk, AstraZeneca, Astellas Pharma |
| 301 | Universität Ulm | Germany | 50.6 | 84 | 18 | Novartis, Roche, Bayer |
| 302 | Umeå University | Sweden | 50.6 | 95 | 18 | Johnson & Johnson, Tataa Biocenter, Actelion |
| 303 | Tokyo Medical and Dental University | Japan | 50.6 | 80 | 16 | Fujifilm, Chugai Pharmaceutical Co., PharmaEssentia Corporation |
| 304 | Ajou University | South Korea | 50.5 | 78 | 20 | Samsung, AstraZeneca, DongKook Pharmaceutical |
| 305 | Hanyang University | South Korea | 50.4 | 92 | 13 | Samsung, AbbVie, Pfizer |
| 306 | University of Mississippi | United States | 50.4 | 115 | 15 | Boehringer Ingelheim, Merck & Co. (MSD), American Regent |
| 307 | Tianjin Medical University | China | 50.3 | 79 | 18 | Philips, Jiangsu Hengrui Medicine, Tianjin Institute of Pharmaceutical Research |
| 308 | Chang Gung University | Taiwan | 50.2 | 79 | 20 | Johnson & Johnson, Eisai, Merck & Co. (MSD) |
| 309 | University of Rome Tor Vergata | Italy | 50.2 | 90 | 16 | Johnson & Johnson, Pfizer, Novartis |
| 310 | Dartmouth College | United States | 50.1 | 77 | 17 | Boehringer Ingelheim, Merck & Co. (MSD), Emmes |
| 311 | Tufts University | United States | 50.1 | 86 | 18 | Novartis, Akebia Therapeutics, Pfizer |
| 312 | University of Modena and Reggio Emilia | Italy | 50.1 | 84 | 19 | Gilead Sciences, Novartis, Relmada Therapeutics |
| 313 | Florida College | United States | 50.0 | 78 | 26 | Gilead Sciences, Johnson & Johnson, Novartis |
| 314 | University of Brescia | Italy | 50.0 | 112 | 19 | Novartis, Cytokinetics, Vifor Pharma |
| 315 | Purdue University West Lafayette | United States | 49.6 | 80 | 13 | AbbVie, Merck & Co. (MSD), Akina |
| 316 | Technical University of Denmark | Denmark | 49.6 | 83 | 15 | Nordic Bioscience, Novo Nordisk, Clinical Microbiomics |
| 317 | Northeastern University | United States | 49.5 | 79 | 19 | Almirall, Astellas Pharma, Johnson & Johnson |
| 318 | Army Medical University | China | 49.4 | 88 | 19 | Jiangsu Hengrui Medicine, AstraZeneca, Junshi Biosciences |
| 319 | Sechenov University | Russia | 49.4 | 80 | 14 | BIOCAD, AstraZeneca, R-Pharm |
| 320 | University of Cape Town | South Africa | 49.1 | 80 | 18 | GlaxoSmithKline, Pfizer, Merck & Co. (MSD) |
| 321 | University of Palermo | Italy | 49.0 | 92 | 21 | Echosens, Novartis, Boehringer Ingelheim |
| 322 | Hiroshima University | Japan | 48.8 | 68 | 16 | AstraZeneca, Fujifilm, Konica Minolta |
| 323 | Masaryk University | Czechia | 48.7 | 85 | 21 | Merck & Co. (MSD), Novartis, AbbVie |
| 324 | Chungnam National University | South Korea | 48.6 | 74 | 14 | Samsung, AntiCancer, Phenikaa |
| 325 | SUNY Upstate Medical University | United States | 48.5 | 94 | 16 | Foundation Medicine, AbbVie, Johnson & Johnson |
| 326 | Kyoto Prefectural University of Medicine | Japan | 48.3 | 77 | 18 | Merck KGaA, Panasonic, Eisai |
| 327 | University of Malaya | Malaysia | 48.2 | 102 | 17 | Johnson & Johnson, Echosens, Merck & Co. (MSD) |
| 328 | Gifu University | Japan | 48.1 | 76 | 15 | Kansai Electric Power, Nippon Telegraph And Telephone West Corporation, NTT |
| 329 | Griffith University | Australia | 48.1 | 90 | 16 | AbbVie, UCB Pharma, Johnson & Johnson |
| 330 | Université d'Angers | France | 48.0 | 84 | 20 | Echosens, Pfizer, Roche |
| 331 | Nihon University | Japan | 47.9 | 83 | 13 | Boehringer Ingelheim, UCB Pharma, Daiichi Sankyo |
| 332 | Universidade Federal de São Paulo | Brazil | 47.8 | 79 | 17 | Fleury S.A., Galderma, Johnson & Johnson |
| 333 | University of Parma | Italy | 47.6 | 85 | 21 | AstraZeneca, Chiesi, ATS Sardegna |
| 334 | All India Institute of Medical Sciences | India | 47.4 | 65 | 16 | Bayer, Pfizer, Echosens |
| 335 | Temple University | United States | 47.3 | 76 | 18 | Nema Research, Enalare Therapeutics, GlaxoSmithKline |
| 336 | Pusan National University | South Korea | 47.2 | 83 | 15 | Samsung, Johnson & Johnson, Roche |
| 337 | Tsinghua University | China | 46.9 | 68 | 19 | Histoindex, Bayer, BGI Group |
| 338 | Aalborg University | Denmark | 46.9 | 70 | 17 | TriNetX, Novo Nordisk, Pfizer |
| 339 | Chonnam National University | South Korea | 46.8 | 93 | 13 | Johnson & Johnson, Samsung, Hanmi Pharmaceutical |
| 340 | Drexel University | United States | 46.4 | 97 | 12 | Johnson & Johnson, AbbVie, CorEvitas |
| 341 | Université Paris-Est Créteil | France | 46.4 | 87 | 13 | Novartis, Roche, IQVIA |
| 342 | University of Eastern Finland | Finland | 46.3 | 74 | 19 | Boehringer Ingelheim, AstraZeneca, Johnson & Johnson |
| 343 | Guangxi Medical University | China | 46.3 | 86 | 18 | Jiangsu Hengrui Medicine, HUTCHMED (China) Limited, Roche |
| 344 | Ankara University | Turkey | 45.9 | 104 | 15 | Johnson & Johnson, Merck & Co. (MSD), Sanofi |
| 345 | Michigan State University | United States | 45.6 | 84 | 16 | AbbVie, Bayer, Sanofi |
| 346 | Wageningen University & Research | Netherlands | 45.6 | 67 | 19 | Pipestone, Danone, Procter & Gamble |
| 347 | University of Science and Technology of China | China | 45.5 | 80 | 18 | Jiangsu Hengrui Medicine, Merck & Co. (MSD), Genmab |
| 348 | University of Bath | United Kingdom | 45.5 | 68 | 17 | UCB Pharma, Johnson & Johnson, AbbVie |
| 349 | Istanbul University | Turkey | 45.2 | 74 | 18 | Science Farm Ltd., Pfizer, Sanofi |
| 350 | Université de Versailles Saint-Quentin-en-Yvelines | France | 45.1 | 104 | 16 | Johnson & Johnson, Takeda, Bristol-Myers Squibb |
| 350 | Dalian Medical University | China | 45.1 | 84 | 14 | Jiangsu Hengrui Medicine, Philips, Merck & Co. (MSD) |
| 352 | University of Oklahoma | United States | 45.0 | 83 | 19 | ImmunoGen, Immunocore, AstraZeneca |
| 353 | Memorial University of Newfoundland | Canada | 44.8 | 93 | 15 | Johnson & Johnson, Eli Lilly, Akebia Therapeutics |
| 354 | Universidade Estadual de Campinas (UNICAMP) | Brazil | 44.8 | 70 | 19 | BioMarin, Sanofi, Takeda |
| 355 | Aristotle University of Thessaloniki | Greece | 44.7 | 76 | 16 | Hellenic Cooperative Oncology Group, Johnson & Johnson, Novartis |
| 356 | Chulalongkorn University | Thailand | 44.6 | 78 | 13 | AstraZeneca, Gilead Sciences, Novartis |
| 357 | Hebrew University of Jerusalem | Israel | 44.6 | 91 | 15 | AstraZeneca, Novo Nordisk, Merck & Co. (MSD) |
| 358 | University of Dundee | United Kingdom | 44.5 | 77 | 14 | AstraZeneca, Sanofi, GlaxoSmithKline |
| 359 | Augusta University | United States | 44.2 | 67 | 18 | Pfizer, Johnson & Johnson, Adaptive Biotechnologies |
| 360 | Rockefeller University | United States | 44.0 | 81 | 15 | Boehringer Ingelheim, Johnson & Johnson, UCB Pharma |
| 361 | University of Aberdeen | United Kingdom | 44.0 | 64 | 15 | TauRx, Bayer, Astellas Pharma |
| 362 | The University of Texas at Austin | United States | 43.9 | 74 | 12 | Novartis, Johnson & Johnson, AstraZeneca |
| 363 | Shanxi Medical University | China | 43.6 | 86 | 15 | Jiangsu Hengrui Medicine, Suzhou Zelgen Biopharmaceuticals Co., Eli Lilly |
| 364 | University of Perugia | Italy | 42.8 | 83 | 13 | Novartis, Merck & Co. (MSD), Johnson & Johnson |
| 365 | Hacettepe University | Turkey | 41.5 | 66 | 15 | Merck & Co. (MSD), Bayer, GlaxoSmithKline |
| 366 | University of Belgrade | Serbia | 41.2 | 69 | 18 | Johnson & Johnson, Astellas Pharma, Chiasma |
| 367 | University of Ljubljana | Slovenia | 40.9 | 67 | 12 | Krka, Novo Nordisk, AstraZeneca |
| 368 | University of KwaZulu-Natal | South Africa | 40.9 | 50 | 15 | Novartis, Astellas Pharma, Gilead Sciences |
| 369 | Nanjing University of Chinese Medicine | China | 40.8 | 72 | 13 | Kanion Pharmaceutical, Jiangsu Hengrui Medicine, Merck & Co. (MSD) |
| 370 | Universidade Nova de Lisboa | Portugal | 40.7 | 68 | 13 | Johnson & Johnson, Meril Life Sciences, Novartis |
| 371 | Universidade da Coruña | Spain | 40.6 | 60 | 17 | Chondrometrics, Servier, AstraZeneca |
| 372 | University of Zagreb | Croatia | 40.5 | 62 | 16 | Pliva, AbbVie, Syreon Research Institute |
| 373 | Université de Strasbourg | France | 40.0 | 71 | 14 | Roche, Boehringer Ingelheim, Galapagos |
| 374 | University of Otago | New Zealand | 40.0 | 55 | 15 | American Regent, Athenex, Southern Community Laboratories |
| 375 | Pennsylvania State University | United States | 40.0 | 66 | 17 | GlaxoSmithKline, Caris Life Sciences, Bioglobe |
| 376 | Kagoshima University | Japan | 39.9 | 55 | 15 | Roche, AbbVie, Genmab |
| 377 | Okayama University | Japan | 39.7 | 56 | 17 | Oncolys BioPharma, Shionogi, Ono Pharmaceutical |
| 378 | University of Göttingen | Germany | 39.7 | 64 | 18 | Novartis, Roche, Vifor Pharma |
| 379 | Kumamoto University | Japan | 39.5 | 72 | 15 | Science Farm Ltd., Ono Pharmaceutical, Daiichi Sankyo |
| 380 | University of Kansas | United States | 39.1 | 72 | 14 | GlaxoSmithKline, Johnson & Johnson, Abbott |
| 381 | St George's, University of London | United Kingdom | 39.0 | 55 | 18 | GlaxoSmithKline, Johnson & Johnson, Merck & Co. (MSD) |
| 382 | Universitat Pompeu Fabra | Spain | 38.8 | 64 | 15 | Roche, Lundbeck, MedSIR |
| 383 | Air Force Medical University | China | 38.6 | 79 | 11 | Jiangsu Hengrui Medicine, Siemens, Merck & Co. (MSD) |
| 384 | Université de Rennes | France | 38.6 | 62 | 15 | Roche, IPPMed, Novartis |
| 385 | University of New Mexico | United States | 38.5 | 76 | 11 | Johnson & Johnson, GlaxoSmithKline, Intra Cellular Therapies |
| 386 | West Virginia University | United States | 38.4 | 69 | 14 | Caris Life Sciences, Pfizer, Medtronic |
| 387 | Texas Tech University | United States | 38.4 | 64 | 15 | AbbVie, Chiesi, Agendia |
| 388 | University of Warwick | United Kingdom | 37.9 | 60 | 15 | GlaxoSmithKline, Vifor Pharma, Abbott |
| 388 | Saint Louis University | United States | 37.9 | 58 | 14 | Eli Lilly, Target PharmaSolutions, Emmes |
| 390 | University of Münster | Germany | 37.8 | 61 | 14 | Johnson & Johnson, Roche, Bayer |
| 391 | Université de Caen Normandie | France | 37.8 | 73 | 15 | Roche, Takeda, Novartis |
| 392 | University of Tennessee at Knoxville | United States | 37.8 | 58 | 16 | Seagen, Takeda, Merck & Co. (MSD) |
| 393 | Swansea University | United Kingdom | 37.6 | 65 | 12 | Novo Nordisk, Bristol-Myers Squibb, Sanofi |
| 394 | Universidade Federal do Rio de Janeiro | Brazil | 37.5 | 64 | 11 | Fleury S.A., Crinetics Pharmaceuticals, Recordati |
| 395 | King Saud University | Saudi Arabia | 37.4 | 62 | 11 | Novo Nordisk, Pfizer, Mars Wrigley Confectionery |
| 396 | Université Clermont Auvergne | France | 37.3 | 62 | 13 | Johnson & Johnson, Valbiotis, Roche |
| 397 | Second Military Medical University | China | 37.2 | 56 | 16 | UCB Pharma, Eli Lilly, Berry Oncology |
| 398 | Ehime University | Japan | 37.1 | 59 | 12 | PharmaEssentia Corporation, Nippon Telegraph And Telephone West Corporation, NTT |
| 399 | Université de Tours | France | 36.7 | 67 | 12 | Roche, Sanofi, Novartis |
| 400 | Xuzhou Medical College | China | 36.1 | 64 | 11 | BeiGene, Jiangsu Hengrui Medicine, 3D Medicines |
| 401 | Ege University | Turkey | 36.0 | 68 | 12 | Merck & Co. (MSD), Sanofi, Eisai |
| 402 | University of Connecticut | United States | 35.9 | 54 | 10 | Bayer, DigiM Solution, Boehringer Ingelheim |
| 403 | Taipei Medical University | Taiwan | 35.6 | 55 | 11 | Johnson & Johnson, Nano Targeting & Therapy Biopharma, Emami |
| 404 | University of Auckland | New Zealand | 35.6 | 73 | 11 | Pfizer, AbbVie, Merck & Co. (MSD) |
| 405 | Nagasaki University | Japan | 35.5 | 46 | 13 | Takeda, Daiichi Sankyo, Astellas Pharma |
| 406 | Tottori University | Japan | 35.5 | 51 | 13 | Takeda, Kyowa Kirin, SBI Pharmaceuticals |
| 407 | University of Nevada, Las Vegas | United States | 35.5 | 58 | 12 | Sunrise Medical, Biogen, Roche |
| 408 | Université de Poitiers | France | 35.4 | 56 | 15 | Roche, Takeda, Amgen |
| 409 | Nanjing University | China | 35.4 | 54 | 10 | United Imaging Healthcare, Philips, Betta Pharmaceuticals |
| 410 | Medical University of Warsaw | Poland | 35.3 | 63 | 12 | Recordati, Novartis, Lux Research |
| 411 | University of Oulu | Finland | 35.3 | 53 | 13 | Nordic Bioscience, GlaxoSmithKline, Artialis SA |
| 412 | University of Pecs | Hungary | 35.2 | 72 | 11 | AbbVie, Syreon Research Institute, Crinetics Pharmaceuticals |
| 413 | University of Iceland | Iceland | 35.1 | 62 | 9 | Amgen, Novartis, Thermo Fisher Scientific |
| 414 | University of York | United Kingdom | 34.8 | 65 | 12 | Edwards Lifesciences, Roche, Bristol-Myers Squibb |
| 415 | Jinan University | China | 34.8 | 56 | 8 | Kanion Pharmaceutical, Guangzhou Electronic Technology, New Hope Liuhe |
| 416 | East Carolina University | United States | 34.5 | 53 | 14 | Abbott, AbbVie, Galera Therapeutics |
| 417 | University of Regensburg | Germany | 34.3 | 54 | 15 | Johnson & Johnson, Repha, AbbVie |
| 418 | South China University of Technology | China | 34.0 | 48 | 10 | BGI Group, Kingfa, New Hope Liuhe |
| 419 | Mie University | Japan | 34.0 | 52 | 13 | PharmaEssentia Corporation, Boehringer Ingelheim, Novartis |
| 420 | Yamaguchi University | Japan | 33.8 | 52 | 13 | Ube, Nippon Telegraph And Telephone West Corporation, NTT |
| 421 | University of Bergen | Norway | 33.7 | 68 | 11 | Novartis, Bevital, LifeGlimmer |
| 422 | University of South Carolina | United States | 33.6 | 60 | 14 | Bristol-Myers Squibb, AbbVie, Acadia Pharmaceuticals |
| 423 | Universität Greifswald | Germany | 33.4 | 38 | 13 | Roche, AbbVie, Johnson & Johnson |
| 424 | University of Illinois Urbana-Champaign | United States | 33.2 | 54 | 12 | Van Drunen Farms, VDF FutureCeuticals, Eisai |
| 425 | University of Ferrara | Italy | 33.2 | 61 | 11 | Novartis, GlaxoSmithKline, Bristol-Myers Squibb |
| 426 | University of Toyama | Japan | 32.9 | 52 | 14 | NTT, Nippon Telegraph And Telephone West Corporation, Astellas Pharma |
| 427 | Marche Polytechnic University | Italy | 32.8 | 64 | 11 | Novartis, AbbVie, Johnson & Johnson |
| 428 | Ritsumeikan University | Japan | 32.8 | 24 | 16 | Ono Pharmaceutical, Towa Pharmaceutical, Daiichi Sankyo RD Novare |
| 429 | University of Szeged | Hungary | 32.8 | 52 | 12 | Egis Pharmaceuticals, Pfizer, CycloLab |
| 430 | Vrije Universiteit Brussel | Belgium | 32.7 | 59 | 10 | Johnson & Johnson, GlaxoSmithKline, Medtronic |
| 431 | University of Catania | Italy | 32.5 | 58 | 9 | Novartis, AbbVie, Johnson & Johnson |
| 432 | Post Graduate Institute of Medical Education and Research | India | 32.4 | 48 | 15 | Novartis, AstraZeneca, Recordati |
| 433 | Georgia Institute of Technology | United States | 32.4 | 48 | 18 | Medtronic, Abbott, NeuroPace |
| 434 | Universidade de Santiago de Compostela | Spain | 32.4 | 55 | 11 | GlaxoSmithKline, Synapse, Pfizer |
| 435 | Pontificia Universidad Católica de Chile | Chile | 32.4 | 52 | 13 | Ultragenyx Pharmaceutical, Bristol-Myers Squibb, Merck & Co. (MSD) |
| 436 | University College Cork | Ireland | 32.2 | 43 | 11 | Johnson & Johnson, Novartis, AstraZeneca |
| 437 | Chiang Mai University | Thailand | 31.9 | 58 | 13 | AstraZeneca, Roche, Merck & Co. (MSD) |
| 438 | University of Electronic Science and Technology of China | China | 31.8 | 57 | 9 | Jiangsu Hengrui Medicine, Genecast, PowerChinaSTATE-OWNED |
| 439 | Guangzhou University of Chinese Medicine | China | 31.8 | 48 | 11 | Jiangsu Hengrui Medicine, Philips, HUTCHMED (China) Limited |
| 440 | Tokushima University | Japan | 31.7 | 50 | 10 | NTT, Nippon Telegraph And Telephone West Corporation, Merck & Co. (MSD) |
| 441 | Washington State University | United States | 31.6 | 45 | 12 | BioIVT, Simcyp, Merck & Co. (MSD) |
| 442 | École Polytechnique Fédérale de Lausanne | Switzerland | 31.4 | 48 | 11 | Siemens, Nestlé, Roche |
| 443 | Manipal Academy of Higher Education | India | 31.2 | 44 | 9 | GlaxoSmithKline, Datar Cancer Genetics, Suven Life Sciences |
| 444 | Shantou University | China | 31.1 | 54 | 10 | Jiangsu Hengrui Medicine, BeiGene, Philips |
| 445 | Texas A&M University | United States | 30.8 | 52 | 9 | Bristol-Myers Squibb, Eastman Chemical Company, Milliman |
| 446 | Yamagata University | Japan | 30.8 | 48 | 10 | Pfizer, Merck KGaA, AbbVie |
| 447 | Cairo University | Egypt | 30.7 | 52 | 10 | Hikma Pharmaceuticals, Novartis, Pfizer |
| 448 | North Carolina State University | United States | 30.7 | 53 | 9 | Zoetis, United Therapeutics, IDEXX Laboratories |
| 449 | Université Paris Sciences et Lettres | France | 30.5 | 56 | 14 | Roche, Bayer, Sanofi |
| 450 | Chung-Ang University | South Korea | 30.3 | 54 | 8 | Samsung, Hanmi Pharmaceutical, Bristol-Myers Squibb |
| 451 | University of Chieti-Pescara | Italy | 30.2 | 47 | 10 | AstraZeneca, Percuros, Adelphi Group |
| 452 | University of Newcastle Australia | Australia | 30.0 | 36 | 25 | Pfizer, Eli Lilly, AstraZeneca |
| 453 | University of Vienna | Austria | 30.0 | 39 | 17 | Bayer, Roche, Sanofi |
| 454 | Shanghai University of Traditional Chinese Medicine | China | 29.7 | 58 | 6 | Amway, United Imaging Healthcare, Jiangzhong Pharmaceutical |
| 455 | Martin Luther University Halle-Wittenberg | Germany | 29.6 | 55 | 11 | Roche, Merck & Co. (MSD), Merck KGaA |
| 456 | Pontifícia Universidade Católica do Rio Grande do Sul | Brazil | 29.4 | 51 | 11 | Pfizer, AbbVie, Bristol-Myers Squibb |
| 457 | Kaohsiung Medical University | Taiwan | 29.0 | 48 | 11 | Johnson & Johnson, Gilead Sciences, Eisai |
| 458 | Gunma University | Japan | 29.0 | 50 | 9 | Sanofi, Takeda, Chugai Pharmaceutical Co. |
| 459 | University of Tartu | Estonia | 28.8 | 44 | 10 | Novartis, IQVIA, Johnson & Johnson |
| 460 | Jiangsu University | China | 28.8 | 45 | 9 | Jiangsu Tian Sheng Pharmaceutical, Dian Diagnostics, 3D Medicines |
| 461 | Nankai University | China | 28.5 | 41 | 10 | Philips, Siemens, SyngentaSTATE-OWNED |
| 462 | University of Strathclyde | United Kingdom | 28.4 | 36 | 12 | AstraZeneca, GlaxoSmithKline, Pfizer |
| 463 | University of Galway (Ollscoil na Gaillimhe) | Ireland | 28.4 | 53 | 13 | Johnson & Johnson, Meril Life Sciences, Roche |
| 464 | Université de Reims Champagne-Ardenne | France | 28.3 | 48 | 11 | Roche, Eli Lilly, AstraZeneca |
| 465 | Loma Linda University | United States | 28.1 | 33 | 18 | UroGen Pharma Ltd., AbbVie, Biosense Webster |
| 466 | University of Twente | Netherlands | 28.1 | 40 | 11 | Philip Morris International, Santeon, Transparency in Healthcare |
| 467 | University of California, Berkeley | United States | 28.1 | 45 | 10 | Roche, AbbVie, Eli Lilly |
| 468 | Palacký University Olomouc | Czechia | 28.0 | 54 | 13 | Merck & Co. (MSD), Sanofi, Eisai |
| 469 | Lanzhou University | China | 27.6 | 51 | 10 | Jiangsu Hengrui Medicine, Philips, Ping An |
| 470 | Christian-Albrechts-Universität zu Kiel | Germany | 27.5 | 52 | 12 | Boston Scientific, IQVIA, Bayer |
| 471 | University of Georgia | United States | 27.1 | 53 | 6 | EpiVax, TRS Technologies, Boehringer Ingelheim |
| 472 | Nantong University | China | 27.0 | 48 | 8 | Philips, 3D Medicines, China National Pharmaceutical Group CorporationSTATE-OWNED |
| 473 | Université Paris-Sud | France | 27.0 | 52 | 11 | Roche, Actelion, Merck & Co. (MSD) |
| 474 | University of Hertfordshire | United Kingdom | 26.5 | 36 | 10 | Novartis, GlaxoSmithKline, Johnson & Johnson |
| 475 | Florida Atlantic University | United States | 26.4 | 45 | 10 | Neurelis, NuVasive, Caris Life Sciences |
| 476 | University of Vermont | United States | 26.3 | 50 | 9 | Eli Lilly, Eisai, Medtronic |
| 477 | University of Sussex | United Kingdom | 26.2 | 38 | 10 | Johnson & Johnson, TauRx, Pfizer |
| 478 | Tokyo University of Science | Japan | 26.2 | 42 | 7 | Takeda, AstraZeneca, Ohara Pharmaceutical Co. |
| 479 | Universidade Federal do Rio Grande do Sul | Brazil | 26.1 | 44 | 9 | Johnson & Johnson, Fleury S.A., ADx NeuroSciences |
| 480 | Université Côte d'Azur | France | 26.0 | 54 | 8 | Bristol-Myers Squibb, Merck & Co. (MSD), Gilead Sciences |
| 481 | Otto-von-Guericke-Universität Magdeburg | Germany | 26.0 | 46 | 8 | AbbVie, R-Pharm, Euroimmun Medizinische Labordiagnostika |
| 482 | University of Rostock | Germany | 25.9 | 64 | 9 | Novartis, Pfizer, Centogene |
| 483 | University of Udine | Italy | 25.9 | 50 | 11 | Roche, Johnson & Johnson, Novartis |
| 484 | Uniformed Services University of the Health Sciences | United States | 25.9 | 54 | 10 | BioArctic, ViiV Healthcare, Data Tecnica International |
| 485 | University of Saskatchewan | Canada | 25.9 | 54 | 9 | Johnson & Johnson, Amorfix, CorEvitas |
| 486 | Shinshu University | Japan | 25.4 | 43 | 8 | NTT, Nippon Telegraph And Telephone West Corporation, Boehringer Ingelheim |
| 487 | Konkuk University | South Korea | 24.1 | 51 | 6 | Samsung, Eisai, AstraZeneca |
| 488 | Yeungnam University | South Korea | 23.9 | 40 | 8 | Samsung, Optos Public Limited Company, Hanmi Pharmaceutical |
| 489 | Ewha Womans University | South Korea | 23.8 | 43 | 9 | Samsung, Pfizer, Astellas Pharma |
| 490 | University of Cyprus | Cyprus | 23.3 | 33 | 11 | Novartis, Merck & Co. (MSD), JDP Pharma Consulting |
| 491 | Jiangnan University | China | 23.1 | 33 | 4 | Jiangsu Hengrui Medicine, Junshi Biosciences, Qilu Pharmaceutical Co. |
| 492 | Universidad de Cantabria | Spain | 22.9 | 36 | 9 | Johnson & Johnson, Sanofi, Legend Biotech |
| 493 | SUNY Downstate Health Sciences University | United States | 22.7 | 36 | 8 | Lexicon Pharmaceuticals, Summit Medical Group, Regeneron |
| 494 | Universidad de Alcalá | Spain | 22.7 | 42 | 9 | MedSIR, AstraZeneca, Eli Lilly |
| 495 | Seattle University | United States | 22.5 | 38 | 13 | Johnson & Johnson, Roche, AstraZeneca |
| 496 | Universidad de Oviedo | Spain | 22.4 | 35 | 11 | AstraZeneca, Pfizer, Johnson & Johnson |
| 497 | University of Messina | Italy | 22.4 | 46 | 9 | Pfizer, Bayer, Novartis |
| 498 | Alexandria University | Egypt | 22.3 | 45 | 7 | Novartis, AstraZeneca, Pharco Pharmaceuticals |
| 499 | Norwegian University of Science and Technology | Norway | 22.0 | 36 | 9 | AstraZeneca, Boehringer Ingelheim, Amgen |
| 500 | Universidade Federal de Minas Gerais | Brazil | 21.9 | 40 | 9 | Merck & Co. (MSD), AbbVie, Johnson & Johnson |
| 501 | Queensland University of Technology | Australia | 21.8 | 46 | 8 | Bristol-Myers Squibb, Eisai, Certara |
| 502 | Vilnius University | Lithuania | 21.8 | 45 | 8 | Syreon Research Institute, AstraZeneca, Novo Nordisk |
| 503 | Université de Bourgogne | France | 21.5 | 38 | 10 | Roche, Novartis, Bayer |
| 504 | University of Nevada, Reno | United States | 21.4 | 46 | 8 | Novartis, Roche, Texas Retina Associates |
| 505 | University of Ulster | United Kingdom | 21.1 | 26 | 10 | Randox, Novartis, Boehringer Ingelheim |
| 506 | University of Surrey | United Kingdom | 20.9 | 40 | 7 | Unilever, Bioptic Laboratory, Bayer |
| 507 | Friedrich Schiller University Jena | Germany | 20.9 | 42 | 8 | Evonik, Synlab, Roche |
| 508 | Prince of Songkla University | Thailand | 20.6 | 47 | 7 | AstraZeneca, Novartis, Recordati |
| 509 | Tampere University | Finland | 20.6 | 34 | 10 | Sanofi, Fimlab Laboratories, GlaxoSmithKline |
| 510 | King Abdulaziz University | Saudi Arabia | 20.4 | 33 | 9 | Hikma Pharmaceuticals, AstraZeneca, Pfizer |
| 511 | Jeonbuk National University | South Korea | 20.4 | 40 | 5 | Boehringer Ingelheim, Samsung, Johnson & Johnson |
| 512 | Osaka City University | Japan | 20.3 | 38 | 10 | Eli Lilly, Otsuka, Daiichi Sankyo |
| 513 | University of Hawaiʻi at Mānoa | United States | 20.1 | 62 | 3 | Neurelis, Daiichi Sankyo, TCM Groups |
| 514 | National Cheng Kung University | Taiwan | 19.9 | 35 | 6 | AstraZeneca, Samsung, Daiichi Sankyo |
| 515 | Comenius University Bratislava | Slovakia | 19.9 | 32 | 9 | AstraZeneca, Bayer, Swedish Orphan Biovitrum |
| 516 | University of Córdoba | Spain | 19.7 | 36 | 9 | Novartis, Pfizer, Merck & Co. (MSD) |
| 517 | Ocean University of China | China | 19.3 | 36 | 2 | SyngentaSTATE-OWNED, Geneis Beijing, Jiangsu Ximei Biotechnology |
| 518 | Flinders University | Australia | 19.2 | 36 | 9 | Pfizer, American Regent, Incyte |
| 519 | University of Rhode Island | United States | 19.1 | 31 | 8 | Merck & Co. (MSD), Simcyp, Pfizer |
| 520 | TU Dortmund University | Germany | 18.8 | 28 | 8 | Johnson & Johnson, AbbVie, Bayer |
| 521 | Zhejiang Chinese Medical University | China | 18.7 | 35 | 5 | Simcere Pharmaceutical, Genetron Health (Beijing) Technology |
| 522 | Université Sorbonne Paris Nord | France | 18.6 | 30 | 11 | Roche, Bayer, Novartis |
| 523 | Aston University | United Kingdom | 18.3 | 29 | 7 | Samsung, Gilead Sciences, Aston Particle Technologies |
| 524 | Australian National University | Australia | 18.3 | 38 | 6 | AbbVie, Astellas Pharma, Pfizer |
| 525 | University of Minho | Portugal | 18.2 | 32 | 6 | Bial, Paralab, Boehringer Ingelheim |
| 526 | University of East Anglia | United Kingdom | 18.1 | 34 | 8 | Merck & Co. (MSD), Philips, Novo Nordisk |
| 527 | Ain Shams University | Egypt | 18.1 | 29 | 8 | AbbVie, Hikma Pharmaceuticals, Novo Nordisk |
| 528 | Zhejiang University of Technology | China | 17.4 | 27 | 3 | SyngentaSTATE-OWNED, Zhejiang Share Bio-Pharm, Canget BioTekpharma |
| 529 | University of Trieste | Italy | 17.2 | 42 | 6 | Novartis, Newronika, Cook Medical |
| 530 | University of Patras | Greece | 17.0 | 31 | 7 | Hellenic Cooperative Oncology Group, Johnson & Johnson, Leo Pharma |
| 531 | Technion - Israel Institute of Technology | Israel | 16.8 | 35 | 10 | Merck & Co. (MSD), AstraZeneca, Johnson & Johnson |
| 532 | Universidad Nacional de Córdoba | Argentina | 16.6 | 63 | 3 | AstraZeneca, Novartis, Bayer |
| 533 | South China Agricultural University | China | 16.4 | 25 | 2 | Guangzhou Insighter Biotechnology, Guangdong Wenshi Dahuanong Biotechnology, Guangdong Chimelong Group |
| 534 | Universidade Federal do Paraná | Brazil | 16.0 | 33 | 5 | Crinetics Pharmaceuticals, Pfizer, Fleury S.A. |
| 535 | China Agricultural University | China | 16.0 | 24 | 3 | Beijing WDWK Biotechnology, New Hope Liuhe, Zhejiang Medicine |
| 536 | Peoples' Friendship University of Russia | Russia | 15.8 | 22 | 5 | AstraZeneca, Beiersdorf, AntiCancer |
| 537 | University of Pretoria | South Africa | 15.8 | 30 | 7 | GlaxoSmithKline, Novartis, Merck & Co. (MSD) |
| 538 | University of Chile | Chile | 15.4 | 29 | 7 | Lumos Pharma, Merck & Co. (MSD), Pfizer |
| 539 | Murdoch University | Australia | 14.9 | 34 | 8 | Sanofi, ADx NeuroSciences, Johnson & Johnson |
| 540 | Normandie Université | France | 14.6 | 28 | 9 | Edwards Lifesciences, IPPMed, Roche |
| 541 | Université de Sherbrooke | Canada | 14.6 | 36 | 5 | Novartis, Clovis Oncology, BioArctic |
| 542 | University of Luxembourg | Luxembourg | 14.4 | 35 | 8 | UCB Pharma, Sanofi, Bristol-Myers Squibb |
| 543 | Gazi University | Turkey | 14.4 | 25 | 6 | Bristol-Myers Squibb, Sanofi, Pfizer |
| 544 | University of Mannheim | Germany | 14.3 | 56 | 2 | Boehringer Ingelheim, Novartis, Synlab |
| 545 | Southern University of Science and Technology | China | 14.3 | 33 | 5 | BGI Group, Olympia Diagnostics, QianYan (Shenzhen) Pharmatech |
| 546 | Pohang University of Science and Technology | South Korea | 14.2 | 24 | 6 | OmniaMed, Samsung, ImmunoBiome |
| 547 | University of Crete | Greece | 14.1 | 28 | 9 | Boehringer Ingelheim, Syreon Research Institute, Merck & Co. (MSD) |
| 548 | KTH Royal Institute of Technology | Sweden | 14.0 | 26 | 9 | AstraZeneca, Novo Nordisk, Simcyp |
| 549 | Virginia Tech | United States | 13.9 | 31 | 4 | Indivior, Mycosynthetix, Caris Life Sciences |
| 550 | Stony Brook University | United States | 13.8 | 38 | 3 | Alkermes, Amgen, Boehringer Ingelheim |
| 551 | Florida International University | United States | 13.8 | 32 | 5 | GlaxoSmithKline, Thermo Fisher Scientific, Karyopharm Therapeutics |
| 552 | Universidad Nacional Autónoma de México | Mexico | 13.8 | 28 | 6 | PemexSTATE-OWNED, Elpen Pharmaceutical, Novartis |
| 553 | University of Houston | United States | 13.7 | 30 | 4 | Boehringer Ingelheim, Gilead Sciences, Bristol-Myers Squibb |
| 554 | Indiana University Bloomington | United States | 13.7 | 38 | 6 | Novo Nordisk, Samsung, Perspectum Ltd. |
| 555 | Budapest University of Technology and Economics | Hungary | 13.5 | 22 | 6 | CycloLab, Egis Pharmaceuticals, UCB Pharma |
| 556 | Dokuz Eylül University | Turkey | 13.4 | 25 | 7 | Novartis, Bayer, Roche |
| 557 | Illinois College | United States | 13.4 | 30 | 5 | Cerner, Eisai, Takeda |
| 558 | Lovely Professional University | India | 13.3 | 28 | 3 | Aerogen, Microgen, Micro Labs |
| 559 | Institute of Medical Sciences | India | 13.2 | 26 | 4 | Vyome Therapeutics, MedGenome Labs, Viatris |
| 560 | University of Missouri | United States | 13.1 | 32 | 3 | AbbVie, Ivogen Inc. (Subsidiary of Nanova, Boehringer Ingelheim |
| 561 | Ben-Gurion University of the Negev | Israel | 13.0 | 32 | 5 | Merck & Co. (MSD), AstraZeneca, Eli Lilly |
| 562 | York University | Canada | 13.0 | 29 | 5 | Novo Nordisk, Eli Lilly, Sanofi |
| 563 | University of South Australia | Australia | 12.8 | 26 | 7 | Johnson & Johnson, Pfizer, IQVIA |
| 564 | Guizhou University | China | 12.8 | 22 | 6 | China Tobacco Guizhou IndustrialSTATE-OWNED, China National Pharmaceutical Group CorporationSTATE-OWNED, Qilu Pharmaceutical Co. |
| 565 | Universidad de Málaga | Spain | 12.8 | 26 | 7 | Johnson & Johnson, Novartis, AbbVie |
| 566 | Gyeongsang National University | South Korea | 12.3 | 31 | 5 | Yuhan, Samsung, Novartis |
| 567 | Edith Cowan University | Australia | 12.3 | 26 | 7 | Merck & Co. (MSD), ADx NeuroSciences, Bristol-Myers Squibb |
| 568 | University of Waterloo | Canada | 12.1 | 22 | 8 | Procter & Gamble, Sanofi, Regeneron |
| 569 | University of Maryland, College Park | United States | 12.1 | 21 | 10 | AstraZeneca, Westat, Johnson & Johnson |
| 570 | Xiamen University | China | 11.9 | 23 | 3 | Philips, Beijing Wantai Biological Pharmacy, Inner Mongolia Yili Industrial Group |
| 571 | Universidad de Murcia | Spain | 11.6 | 25 | 6 | Vifor Pharma, Health Economics and Outcomes Research, Bioibérica |
| 572 | Ohio University | United States | 11.6 | 26 | 4 | BioTherapeutics, DermResearch, Sanova |
| 573 | University of Cagliari | Italy | 11.6 | 34 | 6 | ATS Sardegna, Lundbeck, Novartis |
| 574 | The University of Texas at San Antonio | United States | 11.4 | 32 | 6 | Boston Scientific, Regeneron, AstraZeneca |
| 575 | Stellenbosch University | South Africa | 11.2 | 34 | 5 | GlaxoSmithKline, Gilead Sciences, Reed Medical |
| 576 | Philadelphia University | United States | 11.2 | 37 | 3 | Bayer, Day One Biopharmaceuticals, Chimerix |
| 577 | Princeton University | United States | 11.2 | 22 | 8 | GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb |
| 578 | Inha University | South Korea | 11.2 | 27 | 4 | Hanmi Pharmaceutical, Pfizer, Samsung |
| 579 | University of the Basque Country | Spain | 11.1 | 30 | 5 | AstraZeneca, OWL, Fastbase Solutions |
| 580 | University of Graz | Austria | 11.1 | 22 | 2 | QPS, Hermes Arzneimittel, Enzyan Biocatalysis |
| 581 | Tokyo Metropolitan University | Japan | 11.0 | 31 | 6 | PharmaEssentia Corporation, AstraZeneca, Boehringer Ingelheim |
| 582 | Banaras Hindu University | India | 10.9 | 22 | 4 | Alembic Pharmaceuticals, Shilpa, MedGenome Labs |
| 583 | Carl von Ossietzky Universität Oldenburg | Germany | 10.8 | 20 | 9 | Takeda, Roche, Blueprint Medicines |
| 584 | University of Hull | United Kingdom | 10.6 | 22 | 4 | Novartis, Roche, Novo Nordisk |
| 585 | Technische Universität Braunschweig | Germany | 10.5 | 22 | 5 | Novartis, Merck KGaA, Nestlé |
| 586 | La Trobe University | Australia | 10.5 | 30 | 5 | Digital Health Cooperative Research Centre, Curis, AbbVie |
| 587 | University of Salerno | Italy | 10.5 | 28 | 7 | TOMTEC Imaging Systems GmbH, Johnson & Johnson, AstraZeneca |
| 588 | University of Guelph | Canada | 10.5 | 24 | 4 | IDEXX Laboratories, A.I. VALI, VenatoRx Pharmaceuticals |
| 589 | Bielefeld University | Germany | 10.5 | 25 | 5 | UCB Pharma, Zogenix, Sanofi |
| 590 | Auburn University | United States | 10.3 | 32 | 4 | Regeneron, Pharmacology Consulting, Zoetis |
| 591 | Loyola University Chicago | United States | 10.2 | 28 | 5 | Exact Sciences, Berry Consultants, Bristol-Myers Squibb |
| 592 | Khon Kaen University | Thailand | 10.0 | 30 | 5 | AstraZeneca, Gilead Sciences, Exelixis |
| 593 | Dongguk University | South Korea | 9.6 | 26 | 6 | Amyloid Solution, YUNOVIA, Eisai |
| 594 | Iowa State University | United States | 9.5 | 24 | 5 | Pipestone, Roche, Cargill |
| 595 | University of St Andrews | United Kingdom | 9.4 | 24 | 5 | GlaxoSmithKline, Nucana, Intervacc |
| 596 | University of Aveiro | Portugal | 9.2 | 20 | 8 | Bayer, MicroDiscovery, Roche |
| 597 | Southeast University | China | 8.9 | 24 | 2 | Abbott, Hansoh Pharma, Handan Norman Technology |
| 598 | Deakin University | Australia | 8.9 | 22 | 4 | CSL, Johnson & Johnson, Mindgardens Neuroscience Network |
| 599 | East China Normal University | China | 8.8 | 24 | 3 | Siemens, Siemens Healthineers, United Imaging Healthcare |
| 600 | Universidade do Estado do Rio de Janeiro | Brazil | 8.8 | 26 | 5 | AstraZeneca, Fleury S.A., L'Oréal |
| 601 | Yangzhou University | China | 8.7 | 23 | 3 | Berry Oncology, Eli Lilly, AstraZeneca |
| 602 | Umm al-Qura University | Saudi Arabia | 8.7 | 22 | 4 | Science Farm Ltd., Dabur Research Foundation, Emami |
| 603 | University of Ioannina | Greece | 8.7 | 27 | 6 | Hellenic Cooperative Oncology Group, Roche, BioRealm |
| 604 | University of Central Florida | United States | 8.6 | 22 | 5 | Gilead Sciences, Astellas Pharma, QLEDCures |
| 605 | The University of Texas Medical Branch at Galveston | United States | 8.5 | 27 | 2 | Merck & Co. (MSD), Johnson & Johnson, Merakris Therapeutics |
| 606 | Eindhoven University of Technology | Netherlands | 8.3 | 22 | 4 | Philips, LifeTec Group, Finceramica |
| 607 | Curtin University | Australia | 8.2 | 26 | 4 | Novartis, Boehringer Ingelheim, Sanofi |
| 608 | Universidad de Buenos Aires | Argentina | 8.2 | 24 | 4 | Novartis, Eli Lilly, Galderma |
| 609 | Kangwon National University | South Korea | 8.1 | 24 | 2 | Samsung, Cosmax Inc., AREZ |
| 610 | Colorado State University | United States | 8.1 | 22 | 3 | MBC Pharma, Zoetis, Entasis Therapeutics |
| 611 | University of Plymouth | United Kingdom | 8.0 | 24 | 4 | Bial, AbbVie, Echosens |
| 612 | Howard University | United States | 7.9 | 20 | 5 | DermResearch, Johnson & Johnson, Novartis |
| 613 | University of Toledo | United States | 7.8 | 22 | 4 | Gradalis, Cerevel Therapeutics, Eli Lilly |
| 614 | Chalmers University of Technology | Sweden | 7.8 | 23 | 3 | AstraZeneca, Antaros Medical, Bayer |
| 615 | University of L'Aquila | Italy | 7.8 | 24 | 3 | Novartis, Dompé, Nema Research |
| 616 | Xi'an Jiaotong University | China | 7.8 | 26 | 6 | Bioglobe, BGI Group, Haier Group |
| 617 | Marmara University | Turkey | 7.7 | 22 | 6 | Pfizer, Echosens, Novartis |
| 618 | Lomonosov Moscow State University | Russia | 7.7 | 20 | 2 | AstraZeneca, HyTest, Agilent Technologies |
| 619 | University of South China | China | 7.6 | 26 | 3 | Burning Rock Biotech, Guangzhou Gloria Bioscience, Tencent |
| 620 | Nanyang Technological University | Singapore | 7.4 | 30 | 3 | Novartis, AstraZeneca, Boehringer Ingelheim |
| 621 | Universidad de Granada | Spain | 7.4 | 24 | 4 | Vircell Microbiologists, Reig Jofre, MedSIR |
| 622 | Johannes Kepler University of Linz | Austria | 7.2 | 22 | 5 | Ultragenyx Pharmaceutical, Calciscon, Engineering Software Steyr |
| 623 | Arizona State University | United States | 7.1 | 24 | 4 | AbbVie, Roche, Avid Radiopharmaceuticals |
| 624 | University of Potsdam | Germany | 7.0 | 22 | 7 | Roche, Johnson & Johnson, Sanofi |
| 625 | Delft University of Technology | Netherlands | 6.5 | 22 | 4 | Medtronic, AstraZeneca, Eli Lilly |
| 626 | UiT The Arctic University of Norway | Norway | 6.5 | 20 | 7 | Merck & Co. (MSD), AstraZeneca, Novartis |
| 627 | Saveetha University | India | 6.5 | 22 | 3 | Aerogen, Emami, Tata Steel |
| 628 | Bar-Ilan University | Israel | 6.2 | 20 | 5 | BioArctic, Euroimmun, Kane Biotech |
| 629 | University of Technology Sydney | Australia | 5.9 | 26 | 2 | Aerogen, UniQure, Eni |
| 630 | University of Reading | United Kingdom | 5.6 | 20 | 4 | Synapse, Scientific Computing Associates, Thames Water |
| 631 | Louisiana State University | United States | 5.3 | 26 | 3 | Abbott, Cytel, Seagen |
| 632 | Liverpool John Moores University | United Kingdom | 5.2 | 24 | 3 | TriNetX, Chiesi, Johnson & Johnson |
| 633 | Keele University | United Kingdom | 5.1 | 22 | 6 | Eli Lilly, AstraZeneca, Pfizer |
| 634 | Universidade Estadual Paulista (Unesp) | Brazil | 5.0 | 21 | 4 | Nanomed, AbbVie, Johnson & Johnson |
| 635 | Shenzhen University | China | 4.7 | 23 | 0 | Ningxia Kangya Pharmaceutical, Predex Pharma, Shenzhen Hicontac Technologies |
| 636 | Institut National des Sciences Appliquées de Lyon | France | 4.4 | 22 | 2 | Roche, Novartis |
| 637 | Korea Advanced Institute of Science and Technology | South Korea | 3.4 | 20 | 3 | Samsung, SoVarGen, Genome Insight |
| 638 | University of Alabama | United States | 2.3 | 20 | 3 | Biogen, Roche, Boehringer Ingelheim |
Leading partners: up to three company groups with the most joint works in the sector. State-owned enterprises are marked; a partner whose name is withheld is not listed.
Funded partnerships (reported, not scored). 1,570 UK and EU projects starting 2021 to 2025 (1,051 UKRI, 519 Horizon) involve a cohort university and a company group whose main sector, by its verified joint works, is this one (403 universities): most often AstraZeneca, Unilever, Pfizer, F. Hoffmann-La Roche, Novartis. Sources: UKRI Gateway to Research harvested 4 Oct 2026; CORDIS bulk files of 2026-10-12 (latest record update 2026-06-10). Funded partnerships cover UK (UKRI Gateway to Research) and EU (Horizon 2020 and Horizon Europe, CORDIS) projects starting 2021 to 2025 only. They are reported, never scored, and a funder record outside these two sources is not visible here.
Abdominal vascular conditions and treatments; Acne and Rosacea Treatments and Effects; Actinomycetales infections and treatment; Advanced Breast Cancer Therapies; Advanced Drug Delivery Systems; Advancements in Transdermal Drug Delivery; Alkaloids: synthesis and pharmacology; Alzheimer's disease research and treatments; Amoebic Infections and Treatments; Analytical Methods in Pharmaceuticals; Antibiotic Resistance in Bacteria; Antibiotic Use and Resistance; Antibiotics Pharmacokinetics and Efficacy; Antimicrobial Peptides and Activities; Antimicrobial Resistance in Staphylococcus; Antimicrobial agents and applications; Antioxidant Activity and Oxidative Stress; Antiplatelet Therapy and Cardiovascular Diseases; Aortic Disease and Treatment Approaches; Autoimmune Neurological Disorders and Treatments; Autophagy in Disease and Therapy; Bacterial Infections and Vaccines; Bioactive Compounds and Antitumor Agents; Biological and pharmacological studies of plants; Bipolar Disorder and Treatment; Bladder and Urothelial Cancer Treatments; Blood disorders and treatments; Bone Tumor Diagnosis and Treatments; Bone health and treatments; Brain Metastases and Treatment; Breast Cancer Treatment Studies; CNS Lymphoma Diagnosis and Treatment; Cancer Diagnosis and Treatment; Cancer Immunotherapy and Biomarkers; Cancer Mechanisms and Therapy; Cancer Research and Treatment; Cancer Research and Treatments; Cancer Treatment and Pharmacology; Cancer therapeutics and mechanisms; Cardiac Arrhythmias and Treatments; Cardiac Valve Diseases and Treatments; Cardiovascular Conditions and Treatments; Chemical synthesis and pharmacological studies; Chemotherapy-induced cardiotoxicity and mitigation; Chemotherapy-induced organ toxicity mitigation; Chemotherapy-related skin toxicity; Chromatography in Natural Products; Chronic Myeloid Leukemia Treatments; Colorectal Cancer Treatments and Studies; Dermatologic Treatments and Research; Diabetes Treatment and Management; Diagnosis and Treatment of Venous Diseases; Diagnosis and treatment of tuberculosis; Drug Solubulity and Delivery Systems; Drug Transport and Resistance Mechanisms; Drug-Induced Adverse Reactions; Drug-Induced Hepatotoxicity and Protection; Drug-Induced Ocular Toxicity; Eicosanoids and Hypertension Pharmacology; Endometrial and Cervical Cancer Treatments; Endometriosis Research and Treatment; Epilepsy research and treatment; Erythropoietin and Anemia Treatment; Esophageal Cancer Research and Treatment; Forensic Toxicology and Drug Analysis; Gastroesophageal reflux and treatments; Gastrointestinal Bleeding Diagnosis and Treatment; Gastrointestinal Tumor Research and Treatment; Gastrointestinal disorders and treatments; Glioma Diagnosis and Treatment; Growth Hormone and Insulin-like Growth Factors; Gynecological conditions and treatments; HIV Research and Treatment; HIV-related health complications and treatments; HIV/AIDS drug development and treatment; Heart Failure Treatment and Management; Hemophilia Treatment and Research; Hepatocellular Carcinoma Treatment and Prognosis; Herpesvirus Infections and Treatments; Hidradenitis Suppurativa and Treatments; Histiocytic Disorders and Treatments; Hydrogen's biological and therapeutic effects; Immune responses and vaccinations; Immunotherapy and Immune Responses; Infectious Disease Case Reports and Treatments; Inhalation and Respiratory Drug Delivery; Leprosy Research and Treatment; Liver Disease Diagnosis and Treatment; Lung Cancer Diagnosis and Treatment; Lung Cancer Treatments and Mutations; Lymphatic Disorders and Treatments; Lymphoma Diagnosis and Treatment; Macrophage Migration Inhibitory Factor; Marine Sponges and Natural Products; Medical Research and Treatments; Medical and Pharmaceutic Studies; Medical research and treatments; Medication Adherence and Compliance; Medicinal Plant Pharmacodynamics Research; Menopause: Health Impacts and Treatments; Microbial Natural Products and Biosynthesis; Moyamoya disease diagnosis and treatment; Multiple Myeloma Research and Treatments; Musculoskeletal synovial abnormalities and treatments; Myeloproliferative Neoplasms: Diagnosis and Treatment; Nail Diseases and Treatments; Nanoparticle-Based Drug Delivery; Nanoplatforms for cancer theranostics; Natural Compounds in Disease Treatment; Natural Products and Biological Research; Natural product bioactivities and synthesis; Neuroblastoma Research and Treatments; Neurological disorders and treatments; Nigella sativa pharmacological applications; Ocular Disorders and Treatments; Ocular Infections and Treatments; Ocular Oncology and Treatments; Opioid Use Disorder Treatment; Oral health in cancer treatment; Osteoarthritis Treatment and Mechanisms; Ovarian cancer diagnosis and treatment; PARP inhibition in cancer therapy; Pain Management and Opioid Use; Pain Management and Treatment; Pain Mechanisms and Treatments; Pancreatitis Pathology and Treatment; Paraquat toxicity studies and treatments; Parasitic Diseases Research and Treatment; Parathyroid Disorders and Treatments; Parkinson's Disease Mechanisms and Treatments; Patient Safety and Medication Errors; Pediatric Hepatobiliary Diseases and Treatments; Periodontal Regeneration and Treatments; Pharmaceutical Practices and Patient Outcomes; Pharmaceutical Quality and Counterfeiting; Pharmaceutical industry and healthcare; Pharmaceutical studies and practices; Pharmacogenetics and Drug Metabolism; Pharmacological Effects and Toxicity Studies; Pharmacological Effects of Medicinal Plants; Pharmacological Effects of Natural Compounds; Pharmacological Receptor Mechanisms and Effects; Pharmacology and Nanomedicine Research; Pharmacology and Obesity Treatment; Pharmacovigilance and Adverse Drug Reactions; Pharmacy and Medical Practices; Photodynamic Therapy Research Studies; Phytochemical and Pharmacological Studies; Phytochemicals and Antioxidant Activities; Pituitary Gland Disorders and Treatments; Plant Toxicity and Pharmacological Properties; Platelet Disorders and Treatments; Pneumocystis jirovecii pneumonia detection and treatment; Poisoning and overdose treatments; Pregnancy and Medication Impact; Prostate Cancer Diagnosis and Treatment; Prostate Cancer Treatment and Research; Psoriasis: Treatment and Pathogenesis; Pulmonary Hypertension Research and Treatments; Renal Transplantation Outcomes and Treatments; Renal cell carcinoma treatment; Retinal Diseases and Treatments; Rheumatoid Arthritis Research and Therapies; Safe Handling of Antineoplastic Drugs; Salivary Gland Tumors Diagnosis and Treatment; Sarcoma Diagnosis and Treatment; Schizophrenia research and treatment; Sepsis Diagnosis and Treatment; Soft tissue tumors and treatment; Spondyloarthritis Studies and Treatments; Streptococcal Infections and Treatments; Synthesis and pharmacology of benzodiazepine derivatives; Syphilis Diagnosis and Treatment; Tannin, Tannase and Anticancer Activities; Testicular diseases and treatments; Therapeutic Uses of Natural Elements; Thyroid Cancer Diagnosis and Treatment; Thyroid Disorders and Treatments; Treatment of Major Depression; Trigeminal Neuralgia and Treatments; Urological Disorders and Treatments; Uterine Myomas and Treatments; Veterinary Pharmacology and Anesthesia; vaccines and immunoinformatics approaches
Open data
The full Pharmaceuticals and Therapeutics ranking (rank, university, country, score, sector works, partners and leading partners) as an Excel workbook. Every other index is in the all-indices workbook.
Released under CC BY 4.0: reuse freely with attribution to the Industry Collaboration Index, Global Research Partnerships. How it is measured.